Search Results - "García‐Suárez, Julio"
-
1
Impact of early palliative care intervention in autologous bone marrow transplantation: feasibility of a multicentric study
Published in BMC palliative care (25-07-2024)“…This prospective multicentre study evaluates the impact of Palliative Care Unit (PCU) intervention (Experimental Group, EG), during autologous hematopoietic…”
Get full text
Journal Article -
2
Risk Factors and Mortality of COVID‐19 in Patients With Lymphoma: A Multicenter Study
Published in HemaSphere (01-03-2021)“…Patients with cancer are poorly represented in coronavirus disease 2019 (COVID‐19) series, and heterogeneous series concerning hematology patients have been…”
Get full text
Journal Article -
3
SARS-CoV-2-Specific T Lymphocytes Analysis in mRNA-Vaccinated Patients with B-Cell Lymphoid Malignancies on Active Treatment
Published in Vaccines (Basel) (26-08-2024)“…Patients with B-lymphocyte malignancies (BCMs) receiving B-lymphocyte-targeted therapies have increased risk of severe COVID-19 outcomes and impaired antibody…”
Get full text
Journal Article -
4
Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real‐world study
Published in Cancer medicine (Malden, MA) (01-11-2021)“…Background Lymphoid neoplasms treatment has recently been renewed to increase antitumor efficacy and conventional chemotherapies toxicities. Limited data have…”
Get full text
Journal Article -
5
Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia
Published in Leukemia research (01-01-2016)“…Highlights • Prognostic impact of MRD after induction therapy by flow cytometry in 306 AML patients. • Allogeneic transplantation is better than autologous in…”
Get full text
Journal Article -
6
Two‐weekly dose‐adjusted (DA)‐EPOCH‐like chemotherapy with high‐dose dexamethasone plus rituximab (DA‐EDOCH14‐R) in poor‐prognostic untreated diffuse large B‐cell lymphoma
Published in British journal of haematology (01-02-2013)“…Summary The activity and safety of two‐weekly dose‐adjusted (DA)‐EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin)‐like chemotherapy…”
Get full text
Journal Article -
7
Jumping Translocation in a Patient with Acute Leukemia and Fatal Evolution
Published in Case reports in oncology (01-09-2020)“…Jumping translocations are uncommon cytogenetic abnormalities in which a segment of a donor chromosome, often 1q, is transferred to two or more receptor…”
Get full text
Journal Article -
8
Dose‐adjusted EPOCH plus rituximab is an effective regimen in patients with poor‐prognostic untreated diffuse large B‐cell lymphoma: results from a prospective observational study
Published in British journal of haematology (01-01-2007)“…Summary This study was designed to assess the efficacy and safety of an infusional DA‐EPOCH (dose‐adjusted etoposide/vincristine/doxorubicin/bolus…”
Get full text
Journal Article -
9
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study
Published in Journal of hematology and oncology (08-10-2020)“…Abstract Background Patients with cancer have been shown to have a higher risk of clinical severity and mortality compared to non-cancer patients with…”
Get full text
Journal Article -
10
-
11
Comprehensive evaluation of genetic and acquired thrombophilia markers for an individualized prediction of clinical thrombosis in patients with lymphoma and multiple myeloma
Published in Journal of thrombosis and thrombolysis (01-08-2024)“…Patients diagnosed with lymphoma or multiple myeloma are at elevated risk of venous thromboembolism (VTE). Optimum risk stratification and effective…”
Get full text
Journal Article -
12
HCV‐associated thrombocytopenia: clinical characteristics and platelet response after recombinant α2b‐interferon therapy
Published in British journal of haematology (01-07-2000)“…Hepatitis C virus (HCV) has been proposed as a possible causative agent of chronic thrombocytopenia. We investigated HCV infection in a series of 51 unselected…”
Get full text
Journal Article -
13
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry
Published in Haematologica (Roma) (01-01-2024)“…Treatment options for patients with secondary acute myeloid leukemia (sAML) and AML with myeloid-related changes (AMLMRC) aged 60 to 75 years are scarce and…”
Get full text
Journal Article -
14
COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study
Published in Cancers (27-02-2023)“…Mortality rates for COVID-19 have declined over time in the general population, but data in patients with hematologic malignancies are contradictory. We…”
Get full text
Journal Article -
15
COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant
Published in Cancers (01-01-2024)“…A greater understanding of clinical trends in COVID-19 outcomes among patients with hematologic malignancies (HM) over the course of the pandemic, particularly…”
Get full text
Journal Article -
16
A team-based multidisciplinary approach to managing peripherally inserted central catheter complications in high-risk haematological patients: a prospective study
Published in Supportive care in cancer (01-01-2016)“…Purpose Use of peripherally inserted central catheters (PICCs) has markedly increased during the last decade. However, there are few studies on use of PICCs in…”
Get full text
Journal Article -
17
Nonfatal pulmonary Trichoderma viride infection in an adult patient with acute myeloid leukemia: report of one case and review of the literature
Published in Diagnostic microbiology and infectious disease (01-09-2005)“…Trichoderma species have been recognized to be pathogenic in immunosuppressed hosts with increasing frequency. Trichoderma species are responsible for…”
Get full text
Journal Article -
18
PB2618: USE AND DISCONTINUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA: A SINGLE CENTRE EXPERIENCE
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
19
Changes in the natural history of progressive multifocal leukoencephalopathy in HIV‐negative lymphoproliferative disorders: Impact of novel therapies
Published in American journal of hematology (01-12-2005)“…The aims of this study were to evaluate the clinical characteristics of HIV‐negative patients affected by lymphoproliferative disorders (LPD) who developed…”
Get full text
Journal Article -
20
Myelodysplastic syndrome with erythroid hypoplasia/aplasia: A case report and review of the literature
Published in American journal of hematology (01-08-1998)“…Myelodysplastic syndrome (MDS) with erythroid hypoplasia/aplasia has not yet been clearly defined, and in most patients it is mistaken for acquired pure red…”
Get full text
Journal Article